Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Organon Pharma (UK) Limited, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK
Diprosalic 0.05% w/w / 3% w/w Ointment.
| Pharmaceutical Form |
|---|
|
Ointment. |
Betamethasone Dipropionate 0.064% w/w*
(* equivalent to 0.05% Betamethasone)
Salicylic Acid 3.00% w/w
| Active Ingredient | Description | |
|---|---|---|
| Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
| Salicylic acid |
Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. |
| List of Excipients |
|---|
|
Liquid paraffin |
15, 30 or 100 gm expoxy-lined aluminium tubes with plastic caps.
Not all pack sizes may be marketed.
Organon Pharma (UK) Limited, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK
PL 00025/0570
10 June 1986 / 29 July 2004
| Drug | Countries | |
|---|---|---|
| DIPROSALIC | Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Malta, Netherlands, Poland, Romania, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
